In people with advanced liver cirrhosis, an overgrowth of Candida fungi is commonly found alongside bacterial populations dominated by Enterococcus, and this combination is associated with a higher...

Pro

Against

Mechanism

Synthesis from 1 study

How it works

Antibiotics wipe out helpful gut bacteria, letting harmful ones like Enterococcus and Candida take over. This weakens the gut lining, allowing microbes and their parts to leak into the blood, which triggers a strong but confusing immune response that makes it harder for the body to fight off fungal...

Most probable mechanism

In Simple Terms

When antibiotics kill off many good gut bacteria, it lets harmful bacteria like Enterococcus take over and removes natural checks on fungi like Candida. Without enough good bacteria to keep the gut lining strong, it becomes leaky, letting bacterial and fungal parts escape into the bloodstream. This triggers a strong immune response that weakens the body’s ability to fight off infections, making fungal infections more likely.

Causal chain

Broad-spectrum antibiotic use reduces overall bacterial diversity and abundance, selectively enriching Enterococcus species while depleting short-chain fatty acid-producing commensals

Verified by multiple studies

which leads to

Depletion of short-chain fatty acid-producing bacteria reduces energy supply to intestinal epithelial cells, weakening tight junctions and increasing intestinal permeability

Verified by multiple studies

which leads to

Loss of bacterial competition and antifungal metabolites allows Candida species to proliferate and dominate the fungal community

Verified by multiple studies

which leads to

Increased intestinal permeability enables translocation of bacterial components (e.g., LPS, peptidoglycan) and fungal components (e.g., β-glucans) into the portal circulation

Verified by multiple studies

which leads to

Translocated microbial components activate liver and systemic immune cells via pattern recognition receptors, triggering sustained release of pro-inflammatory cytokines and macrophage activation markers

Verified by multiple studies

which leads to

Chronic systemic inflammation impairs immune surveillance and promotes immune exhaustion, reducing the ability to contain fungal pathogens and increasing susceptibility to invasive fungal infections

Verified by multiple studies

Evidence from Studies

Supporting (1)

Community contributions welcome

Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation

Cross-Sectional Study

Human

2025 Dec

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation

Score: 44

DOI: 10.1080/19490976.2025.2487209

Similar Assertions

In patients with advanced liver cirrhosis, antibiotic use is linked to changes in the gut microbiome, including fewer types of bacteria, a rise in Enterococcus bacteria, and increased Candida fungi.

83%

In patients with advanced liver cirrhosis, the presence of Bifidobacteria as the dominant gut bacteria is associated with higher bacterial diversity, more total bacteria, fewer fungi, and lower levels of systemic inflammation compared to cases where Enterococcus is the dominant gut bacterium.

73%

In people with advanced liver cirrhosis, an imbalance in gut bacteria—specifically high levels of Enterococcus, low bacterial variety, and reduced production of certain bacterial metabolites—is linked to higher levels of a protein that weakens the gut barrier, more widespread inflammation, and more frequent fungal infections.

72%